Published in J Clin Invest on August 01, 1996
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. J Clin Invest (2011) 1.90
Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J Mol Sci (2010) 1.41
Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus. Immunology (2008) 1.38
Enhanced antigen-presenting activity and tumour necrosis factor-alpha-independent activation of dendritic cells following treatment with Mycobacterium bovis bacillus Calmette-Guérin. Immunology (1999) 1.09
Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells. Cancer Res (2008) 1.03
Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response. J Exp Med (2002) 1.02
Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand. BMC Immunol (2002) 0.96
Collapse of the tumor stroma is triggered by IL-12 induction of Fas. Mol Ther (2013) 0.95
Functional changes of dendritic cells derived from allogeneic partial liver graft undergoing acute rejection in rats. World J Gastroenterol (2003) 0.94
Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B - restoration by exogenous interleukin-12. Clin Exp Immunol (2002) 0.90
Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation. Clin Exp Immunol (1998) 0.85
IL-33 promotes innate IFN-γ production and modulates dendritic cell response in LCMV-induced hepatitis in mice. Eur J Immunol (2015) 0.78
The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09
Functional role of type I and type II interferons in antiviral defense. Science (1994) 18.92
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol (1995) 10.65
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med (1989) 10.60
Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol (1994) 8.43
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity (1996) 8.27
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 7.52
Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol (1995) 6.09
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med (1994) 5.20
Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med (1993) 4.49
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med (1995) 3.67
Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol (1991) 3.40
An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol (1996) 3.09
Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med (1994) 2.82
Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol (1995) 2.71
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med (1996) 2.69
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J Clin Invest (1994) 2.57
Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol (1992) 2.37
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science (1993) 2.35
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med (1996) 2.32
Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol (1994) 2.31
Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med (1996) 2.30
Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med (1992) 2.26
Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells. J Exp Med (1990) 2.19
Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology (1994) 1.98
Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J Exp Med (1995) 1.80
Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J Exp Med (1995) 1.78
Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci U S A (1994) 1.56
Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. J Immunol (1993) 1.53
Cytotoxic T lymphocytes specific for influenza virus. Curr Top Microbiol Immunol (1994) 1.43
IL-12 synthesis by human Langerhans cells. J Immunol (1996) 1.43
Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur J Immunol (1993) 1.32
Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15. J Exp Med (1995) 1.25
Interleukin-12 gene expression after viral infection in the mouse. J Virol (1995) 1.22
Human interferon alpha and gamma production by lymphocytes during the generation of influenza virus-specific cytotoxic T lymphocytes. J Gen Virol (1986) 1.14
Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc Natl Acad Sci U S A (1994) 1.11
IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity. J Immunol (1988) 1.08
Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity. Implications for the age-related decline in CTL. J Immunol (1994) 0.98
Expression of cytokine mRNA in murine splenic dendritic cells and better induction of T cell-derived cytokines by dendritic cells than by macrophages during in vitro costimulation assay using specific antigens. J Leukoc Biol (1995) 0.91
Lymphocyte responses and cytokines. Cell (1994) 8.35
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science (2011) 4.72
DNA vaccines: immunology, application, and optimization*. Annu Rev Immunol (2000) 4.51
Activation events during thymic selection. J Exp Med (1992) 3.43
Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Exp Med (1997) 2.81
Induction and regulation of IL-15 expression in murine macrophages. J Immunol (1996) 2.28
Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol (1994) 2.25
Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat Med (1998) 1.99
IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J Immunol (1995) 1.94
The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge. J Immunol (2001) 1.72
Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl Acad Sci U S A (1993) 1.71
The rates of blindness and of partial sight registration in glaucoma patients. Eye (Lond) (2000) 1.71
The distinctive features of influenza virus infection of dendritic cells. Immunobiology (1998) 1.70
GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology (2011) 1.69
Lymphokine and cytokine production by Fc epsilon RI+ cells. Adv Immunol (1993) 1.67
The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc Natl Acad Sci U S A (2000) 1.55
Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci U S A (1994) 1.47
Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells. J Immunol (2000) 1.45
DNA vaccines: a key for inducing long-term cellular immunity. Curr Opin Immunol (2000) 1.42
Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma. J Immunol (1998) 1.42
CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J Immunol (1998) 1.32
The protozoan parasite Toxoplasma gondii targets proteins to dense granules and the vacuolar space using both conserved and unusual mechanisms. J Cell Biol (1998) 1.27
Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J Immunol (1998) 1.26
CD40 ligand/CD40 stimulation regulates the production of IFN-gamma from human peripheral blood mononuclear cells in an IL-12- and/or CD28-dependent manner. J Immunol (1998) 1.20
Neoplasia in zebrafish (Danio rerio) treated with 7,12-dimethylbenz[a]anthracene by two exposure routes at different developmental stages. Toxicol Pathol (2001) 1.19
CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis. Infect Immun (2000) 1.19
Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N'-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol Pathol (2001) 1.19
Alcohol dehydrogenase in Drosophila: isolation and characterization of messenger RNA and cDNA clone. Nucleic Acids Res (1980) 1.17
Dealing from the evolutionary pawnshop: how lymphocytes make decisions. Immunity (1999) 1.15
Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro. Am J Pathol (1994) 1.13
CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum. J Exp Med (1998) 1.12
Patients with multidrug-resistant tuberculosis with low CD4+ T cell counts have impaired Th1 responses. J Immunol (1997) 1.10
T helper cell differentiation in immune response. Curr Opin Immunol (1995) 1.10
Regulation of transforming growth factor-beta production by interleukin-12. Eur J Immunol (1997) 1.09
Fc epsilon receptor-positive cells are a major source of antigen-induced interleukin-4 in spleens of mice infected with Schistosoma mansoni. Eur J Immunol (1993) 1.03
Cytokine regulation of IL-12 receptor beta2 expression: differential effects on human T and NK cells. Eur J Immunol (2000) 1.02
Assessing horizontal transfer of nifHDK genes in eubacteria: nucleotide sequence of nifK from Frankia strain HFPCcI3. Mol Biol Evol (1995) 1.00
Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum. Infect Immun (1997) 0.99
Experimental infection of Rana pipiens tadpoles with Echinostoma trivolvis cercariae. Parasitol Res (1997) 0.96
Costochondritis. A prospective analysis in an emergency department setting. Arch Intern Med (1994) 0.96
Proteomic analysis of the genotoxicant methylazoxymethanol (MAM)-induced changes in the developing cerebellum. J Proteome Res (2006) 0.95
Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms. J Immunol (1999) 0.93
Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5. Br J Ophthalmol (2006) 0.91
A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells. Int J Oncol (2009) 0.91
Aging alters the entraining effects of an activity-inducing stimulus on the circadian clock. Brain Res (1993) 0.89
The risk of complications of uveitis in a district hospital cohort. Br J Ophthalmol (2004) 0.87
Differential requirement of IFN consensus sequence binding protein for the production of IL-12 and induction of Th1-type cells in response to IFN-gamma. J Immunol (1999) 0.87
Blindness following a diabetic foot infection: a variant to the 'eye-foot syndrome'? Diabet Med (2000) 0.86
Amyloid tumor of the stomach simulating an obstructing gastric carcinoma: case report and review of the literature. Endoscopy (2009) 0.85
Molecular and cellular determinants of immunity to Histoplasma capsulatum. Res Immunol (1998) 0.84
p73 is over-expressed in vulval cancer principally as the Delta 2 isoform. Br J Cancer (2001) 0.84
Nutritional status and cutaneous leishmaniasis in rural Ecuadorian children. J Trop Pediatr (1995) 0.83
The regulation of IL-12: its role in infectious, autoimmune, and allergic diseases. J Allergy Clin Immunol (1998) 0.83
Safe eye surgery: non-technical aspects. Eye (Lond) (2011) 0.83
Effects of diet on the lipid composition of Echinostoma caproni (Trematoda) in ICR mice. Parasitol Res (1997) 0.83
Perforin is required for primary immunity to Histoplasma capsulatum. J Immunol (2001) 0.82
Five unique temperate phages from a polylysogenic strain of Bacillus thuringiensis subsp. aizawai. J Gen Microbiol (1988) 0.82
Endoscopic retrograde cholangio-pancreatography practice in district general hospitals in North East England: a Northern Regional Endoscopy Group (NREG) study. J R Coll Physicians Edinb (2011) 0.82
Ultrastructural characteristics of Fc epsilon R-positive basophils in the spleen and bone marrow of mice immunized with goat anti-mouse IgD antibody. Lab Invest (1993) 0.81
The human G1m1 allotype associates with CD4+ T-cell responsiveness to a highly conserved IgG1 constant region peptide and confers an asparaginyl endopeptidase cleavage site. Genes Immun (2011) 0.80
Regulation of rat maternal behavior by broadband pup vocalizations. Behav Neural Biol (1992) 0.79
Effects of snail-conditioned water from Biomphalaria glabrata on hatching of Echinostoma caproni miracidia. Parasitol Res (1999) 0.78
Covalent binding of (+) 7S-trans-7,8-dihydrobenzo [a]pyrene-7,8-diol to trout DNA: P-450- and peroxidation-dependent pathways. Cancer Lett (1993) 0.77
Dwarfism, occult spinal dysraphism, and presacral myxopapillary ependymoma with an epidermoid cyst in a child. Acta Neurochir (Wien) (2005) 0.77
Infectivity and growth of Echinostoma revolutum (Froelich, 1802) in the domestic chick. Int J Parasitol (1997) 0.77
Primary Mycobacterium avium complex septic arthritis in a patient with AIDS. Clin Infect Dis (1995) 0.77
Improvement in CD4 lymphocyte count in HIV-Reiter's syndrome after treatment with sulfasalazine. J Rheumatol (1994) 0.76
Electrical stimulation as a therapeutic option to improve eyelid function in chronic facial nerve disorders. Invest Ophthalmol Vis Sci (1999) 0.76
Oxidation of polycyclic hydrocarbons by oxygen radicals. Princess Takamatsu Symp (1990) 0.76
Aspirin on trial. Nature (1993) 0.75
Chemoattraction and penetration of Echinostoma trivolvis and E. caproni cercariae in the presence of Biomphalaria glabrata, Helisoma trivolvis, and Lymnaea elodes dialysate. Parasitol Res (1997) 0.75
Postmetacercarial changes in Echinostoma caproni maintained in a defined medium plus calf serum. Korean J Parasitol (2000) 0.75
Timed treatment of the arthritic diseases: a review and hypothesis. Semin Arthritis Rheum (1992) 0.75
Comparative studies on excystation and morphological features of the metacercariae of Echinostoma paraensei and E. caproni. Int J Parasitol (1997) 0.75
Images in clinical practice. Progeria. Indian Pediatr (1997) 0.75
Management of diabetic foot lesions with limited use of antibodies. Ann Saudi Med (1993) 0.75
Maintenance of the life cycle of Echinostoma trivolvis (Trematoda) in dexamethasone-treated ICR mice and laboratory-raised Helisoma trivolvis (Gastropoda). Parasitol Res (1997) 0.75
Reversible cardiogenic shock in a patient with lupus myocarditis. J Rheumatol (1993) 0.75
Mesenteric fat necrosis after recent surgery causing bowel obstruction: a case report and review of the literature. J Postgrad Med (2012) 0.75
Maintenance of Helisoma trivolvis naturally infected with Echinostoma trivolvis in spring water at 4 degrees C for 300 days. J Helminthol (1998) 0.75
The aromatic amino acid decarboxylase inhibitor, NSD-1015, increases release of dopamine: response characteristics. Neuropharmacology (1992) 0.75
Weight change, ideal weight and hypertension. Curr Opin Nephrol Hypertens (1999) 0.75
Effects of high fat diets on worm recovery, growth and distribution of Echinostoma caproni in ICR mice. J Helminthol (1996) 0.75
Dendritic cells as immunogens for human CTL responses. Adv Exp Med Biol (1997) 0.75
A transsexual patient with bilateral central retinal vein occlusions. Eye (Lond) (2000) 0.75